Also known as Growth Hormone Releasing Peptide-6 · Growth hormone-releasing hexapeptide · GHRP
The original growth-hormone-releasing peptide — the tool compound that led scientists to the ghrelin receptor and, ultimately, to ghrelin itself.
Research refreshed
GHRP-6 is the first-generation growth-hormone-releasing peptide and the historical starting point of the entire GHRP field. A synthetic hexapeptide that activates the GHS-R1a (ghrelin) receptor, it is pivotal beyond its own effects: the hunt for the receptor GHRP-6 bound led to the 1996 cloning of the GH-secretagogue receptor and, in 1999, to the discovery of its natural ligand, ghrelin.
GHRP-6 is where the story of this whole class begins. Grown out of Cyril Bowers’ work on enkephalin-derived peptides, it was among the first peptides shown to release growth hormone through a receptor entirely separate from GHRH. That receptor was an orphan — no one knew its natural ligand — and GHRP-6 became the pharmacological probe used to find it.
The payoff was foundational: in 1996 the GH-secretagogue receptor (GHS-R1a) was cloned, and in 1999 its endogenous ligand, the stomach hormone ghrelin, was identified — reframing GHRP-6 in hindsight as a synthetic mimic of a hormone that had not yet been discovered. Pharmacologically, GHRP-6’s other signature is appetite: it is the GHRP most associated with a sharp, ghrelin-like spike in hunger, which itself became a research tool for probing feeding circuits. It is not FDA-approved.
GHS-R1a (ghrelin receptor) agonism → GH release and appetite stimulation.
Behind every vial of GHRP-6 is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how GHRP-6, specifically, is brought into being.
On paper, GHRP-6 is C46H56N12O6 — about 873.04 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
GHRP-6's chain is short but unusual — it carries D-amino acids that help it resist enzymatic breakdown, but demand specialized, costlier building blocks and careful coupling on the synthesizer. Its C-terminus is amidated rather than left as a free acid — a defined modification the synthesis has to deliver, not an afterthought.
The crude mixture — GHRP-6 plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of GHRP-6 proves itself: identity confirmed by mass spectrometry against its ~873.04 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of GHRP-6 — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
A hexapeptide amide built from standard Fmoc building blocks, including D-Trp and D-Phe. A short, straightforward solid-phase assembly; the main concerns are C-terminal amidation and protecting the oxidation- and light-sensitive tryptophan residues during synthesis and storage.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
GHRP-6 is the first growth-hormone-releasing peptide — a synthetic hexapeptide that releases GH by activating the ghrelin receptor, and the compound whose study led to the discovery of that receptor and of ghrelin itself.
It was the pharmacological probe used to identify the GH-secretagogue receptor (cloned 1996) and its natural hormone, ghrelin (1999) — making it foundational to a whole area of endocrinology.
It activates the ghrelin receptor, and ghrelin is the body’s hunger signal; GHRP-6 is the GHRP most associated with a sharp increase in appetite.
GHRP-6 is the original and least selective; GHRP-2 was tuned for more potency and less hunger, and ipamorelin for GH release with minimal cortisol or prolactin.
No — it is a research compound. This page is a research and educational reference.
Recombinant 191-amino-acid human growth hormone — a folded protein biologic identical in sequence to pituitary GH, not a synthetic research peptide.
ViewThe downstream effector of growth hormone — a 70-amino-acid recombinant protein, structurally a cousin of proinsulin, that carries out most of GH’s growth signal.
ViewA long-acting modified IGF-1 analog with reduced IGFBP binding and prolonged systemic activity.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.